Author's Response

Affiliations

Comment

Ben Kang et al. J Pediatr Gastroenterol Nutr. 2015 Sep.

. 2015 Sep;61(3):e15.

doi: 10.1097/MPG.0000000000000883.

¹ Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

No abstract available

Comment on

Infliximab "Top-Down" Strategy is Superior to "Step-Up" in Maintaining Long-Term Remission in the Treatment of Pediatric Crohn Disease.
Lee YM, Kang B, Lee Y, Kim MJ, Choe YH. Lee YM, et al. J Pediatr Gastroenterol Nutr. 2015 Jun;60(6):737-43. doi: 10.1097/MPG.0000000000000711. J Pediatr Gastroenterol Nutr. 2015. PMID: 25564801
Infliximab More Effective in Therapy-Naïve Than in Therapy-Refractory Patients.
Cozijnsen MA, de Ridder L. Cozijnsen MA, et al. J Pediatr Gastroenterol Nutr. 2015 Sep;61(3):e15. doi: 10.1097/MPG.0000000000000884. J Pediatr Gastroenterol Nutr. 2015. PMID: 26111298 No abstract available.